Human genetics has provided an opportunity to change this paradigm by enabling the discovery of individuals at risk for toxicity. The continuous QT interval is heritable9, with multiple environmental and genetic contributors. We have used genome-wide association studies (GWAS) to identify over 60 common polymorphisms that collectively explain more of QT interval than all known clinical factors combined. However, our knowledge of the application of this information to the patient level is incomplete.